Subscribe
Healthcare

What Mylan’s CEO learned from the EpiPen outrage

By Paige Winfield Cunningham
Published
Add Washington Examiner on Google
What Mylan’s CEO learned from the EpiPen outrage

SAN FRANCISCO – Mylan CEO Heather Bresch reflected Wednesday on what she learned from months of public outrage over her company’s dramatic price increase for the EpiPen allergy shot.

Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.

Tag:

Epipen Minusextra Paige Winfield Cunningham Pharmaceutical Industry